Author pages are created from data sourced from our academic publisher partnerships and public sources.
Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients
- P. Al Ghazal, K. Herberger, +18 authors J. Dissemond
- Orphanet Journal of Rare Diseases
- 8 September 2013
BackgroundPyoderma gangrenosum (PG) is a rarely diagnosed ulcerative neutrophilic dermatosis with unknown origin that has been poorly characterized in clinical studies so far. Consequently there have… Expand
CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B
- M. Hagn, Verena Ebel, +11 authors B. Jahrsdoerfer
- Biology, Medicine
- European journal of immunology
- 1 July 2010
Recently, we reported that IL‐21 induces granzyme B (GzmB) and GzmB‐dependent apoptosis in malignant CD5+ B cells from patients with chronic lymphocytic leukemia. Several autoimmune diseases (AD) are… Expand
Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study.
- P. Campochiaro, R. Channa, +5 authors Michael T. Stumpp
- American journal of ophthalmology
- 1 April 2013
PURPOSE To evaluate the safety and bioactivity of MP0112, a designed ankyrin repeat protein (DARPin) that specifically binds vascular endothelial growth factor (VEGF) in patients with diabetic… Expand
GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice
- C. Plater-Zyberk, L. Joosten, M. Helsen, J. Hepp, P. Baeuerle, W. B. van den Berg
- Annals of the rheumatic diseases
- 4 October 2006
Objective: The pathogenic involvement of granulocyte-macrophage colony-stimulating factor (GM-CSF) in arthritis has been put forward. We have investigated the therapeutic effect of GM-CSF… Expand
A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration.
- Eva-Maria Krinner, J. Hepp, +23 authors T. Raum
- Biology, Medicine
- Protein engineering, design & selection : PEDS
- 1 October 2006
GM-CSF (granulocyte-macrophage colony stimulating factor) plays a central role in inflammatory processes. Treatment with antibodies neutralizing murine GM-CSF showed significant therapeutic effects… Expand
[Genetic causes of impaired wound healing. Rare differential diagnosis of the non-healing wound].
- K. Elsharkawi-Welt, J. Hepp, K. Scharffetter-Kochanek
- Der Hautarzt; Zeitschrift fur Dermatologie…
- 1 November 2008
Chronic leg ulcers affect about 1% of the German population. The intense search for the underlying cause of impaired wound healing is an essential requirement for successful therapy. The most common… Expand
A human monoclonal IgG1 potently neutralizing the pro-inflammatory cytokine GM-CSF.
The pro-inflammatory cytokine GM-CSF is aberrantly produced in many autoimmune and chronic inflammatory human diseases. GM-CSF neutralization by antibodies has been shown to have a profound… Expand
Macrophages significantly enhance wound healing in a vascularized skin model.
- F. Kreimendahl, Y. Marquardt, +5 authors J. Baron
- Materials Science, Medicine
- Journal of biomedical materials research. Part A
- 1 June 2019
Tissue-engineered dermo-epidermal skin grafts could be applied for the treatment of large skin wounds or used as an in vitro wound-healing model. However, there is currently no skin replacement model… Expand
Abstract 3029: FAP-mediated tumor accumulation of a T-cell agonistic FAP/4-1BB DARPin drug candidate analyzed by SPECT/CT and quantitative biodistribution
Immunomodulating agents have revolutionized anti-cancer therapy. However, monotherapy is often not sufficient, and development of combination treatments is hampered by cumulative toxicity. In an… Expand
Abstract 3752: Preclinical pharmacology of MP0310: A 4-1BB/FAP bispecific DARPin drug candidate promoting tumor-restricted T-cell costimulation
Agonistic antibodies against the T cell costimulatory receptor 4-1BB (CD137) have proved to be very efficacious anti-tumor agents in preclinical animal models. However, clinical development of 4-1BB… Expand